Elimination of mother-to-child transmission of hepatitis B.
暂无分享,去创建一个
R. Ozaras | Bilgul Mete | I. Balkan | F. Tabak | M. Yemisen | B. Mete
[1] C. Thio,et al. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. , 2015, The Lancet. Infectious diseases.
[2] L. Mofenson,et al. Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants , 2011, Antimicrobial Agents and Chemotherapy.
[3] F. Dabis,et al. Plasma and Intracellular Tenofovir Pharmacokinetics in the Neonate (ANRS 12109 Trial, Step 2) , 2011, Antimicrobial Agents and Chemotherapy.
[4] F. Dabis,et al. Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 , 2010, Antimicrobial Agents and Chemotherapy.
[5] Huy Trinh,et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. , 2008, The New England journal of medicine.